In invasive hepatocellular carcinoma (HCC) and pancreatic cancer, CDK14 overexpression promotes invasiveness and migration and activating mutations of CDK14 have been identified in HPV + HCC patients.455. This evidence concerns the gene CDK14 and familial pancreatic carcinoma.